Cargando…

Osimertinib in Indian patients with T790M-positive advanced nonsmall cell lung cancer

Detalles Bibliográficos
Autores principales: Noronha, Vanita, Majumdar, Swaratika, Joshi, Amit, Patil, Vijay, Trivedi, Vaishakhi, Chougule, Anuradha, Prabhash, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763619/
https://www.ncbi.nlm.nih.gov/pubmed/29404287
http://dx.doi.org/10.4103/sajc.sajc_202_17
_version_ 1783291917565427712
author Noronha, Vanita
Majumdar, Swaratika
Joshi, Amit
Patil, Vijay
Trivedi, Vaishakhi
Chougule, Anuradha
Prabhash, Kumar
author_facet Noronha, Vanita
Majumdar, Swaratika
Joshi, Amit
Patil, Vijay
Trivedi, Vaishakhi
Chougule, Anuradha
Prabhash, Kumar
author_sort Noronha, Vanita
collection PubMed
description
format Online
Article
Text
id pubmed-5763619
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-57636192018-02-05 Osimertinib in Indian patients with T790M-positive advanced nonsmall cell lung cancer Noronha, Vanita Majumdar, Swaratika Joshi, Amit Patil, Vijay Trivedi, Vaishakhi Chougule, Anuradha Prabhash, Kumar South Asian J Cancer Letter to the Editor Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5763619/ /pubmed/29404287 http://dx.doi.org/10.4103/sajc.sajc_202_17 Text en Copyright: © 2017 The South Asian Journal of Cancer http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Letter to the Editor
Noronha, Vanita
Majumdar, Swaratika
Joshi, Amit
Patil, Vijay
Trivedi, Vaishakhi
Chougule, Anuradha
Prabhash, Kumar
Osimertinib in Indian patients with T790M-positive advanced nonsmall cell lung cancer
title Osimertinib in Indian patients with T790M-positive advanced nonsmall cell lung cancer
title_full Osimertinib in Indian patients with T790M-positive advanced nonsmall cell lung cancer
title_fullStr Osimertinib in Indian patients with T790M-positive advanced nonsmall cell lung cancer
title_full_unstemmed Osimertinib in Indian patients with T790M-positive advanced nonsmall cell lung cancer
title_short Osimertinib in Indian patients with T790M-positive advanced nonsmall cell lung cancer
title_sort osimertinib in indian patients with t790m-positive advanced nonsmall cell lung cancer
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763619/
https://www.ncbi.nlm.nih.gov/pubmed/29404287
http://dx.doi.org/10.4103/sajc.sajc_202_17
work_keys_str_mv AT noronhavanita osimertinibinindianpatientswitht790mpositiveadvancednonsmallcelllungcancer
AT majumdarswaratika osimertinibinindianpatientswitht790mpositiveadvancednonsmallcelllungcancer
AT joshiamit osimertinibinindianpatientswitht790mpositiveadvancednonsmallcelllungcancer
AT patilvijay osimertinibinindianpatientswitht790mpositiveadvancednonsmallcelllungcancer
AT trivedivaishakhi osimertinibinindianpatientswitht790mpositiveadvancednonsmallcelllungcancer
AT chouguleanuradha osimertinibinindianpatientswitht790mpositiveadvancednonsmallcelllungcancer
AT prabhashkumar osimertinibinindianpatientswitht790mpositiveadvancednonsmallcelllungcancer